These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 27620165)

  • 1. Vasodilator-Stimulated Phosphoprotein (VASP)-dependent and -independent pathways regulate thrombin-induced activation of Rap1b in platelets.
    Benz PM; Laban H; Zink J; Günther L; Walter U; Gambaryan S; Dib K
    Cell Commun Signal; 2016 Sep; 14(1):21. PubMed ID: 27620165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasodilator-stimulated phosphoprotein (VASP) is phosphorylated on Ser157 by protein kinase C-dependent and -independent mechanisms in thrombin-stimulated human platelets.
    Wentworth JK; Pula G; Poole AW
    Biochem J; 2006 Jan; 393(Pt 2):555-64. PubMed ID: 16197368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The vasodilator-stimulated phosphoprotein (VASP) is involved in cGMP- and cAMP-mediated inhibition of agonist-induced platelet aggregation, but is dispensable for smooth muscle function.
    Aszódi A; Pfeifer A; Ahmad M; Glauner M; Zhou XH; Ny L; Andersson KE; Kehrel B; Offermanns S; Fässler R
    EMBO J; 1999 Jan; 18(1):37-48. PubMed ID: 9878048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dipyridamole synergizes with nitric oxide to prolong inhibition of thrombin-induced platelet shape change.
    Jensen BO; Kleppe R; Kopperud R; Nygaard G; Døskeland SO; Holmsen H; Selheim F
    Platelets; 2011; 22(1):8-19. PubMed ID: 20958117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A noble function of BAY 11-7082: Inhibition of platelet aggregation mediated by an elevated cAMP-induced VASP, and decreased ERK2/JNK1 phosphorylations.
    Lee HS; Kim SD; Lee WM; Endale M; Kamruzzaman SM; Oh WJ; Cho JY; Kim SK; Cho HJ; Park HJ; Rhee MH
    Eur J Pharmacol; 2010 Feb; 627(1-3):85-91. PubMed ID: 19913011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein kinase A mediates inhibition of the thrombin-induced platelet shape change by nitric oxide.
    Jensen BO; Selheim F; Døskeland SO; Gear AR; Holmsen H
    Blood; 2004 Nov; 104(9):2775-82. PubMed ID: 15265792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylation of focal adhesion vasodilator-stimulated phosphoprotein at Ser157 in intact human platelets correlates with fibrinogen receptor inhibition.
    Horstrup K; Jablonka B; Hönig-Liedl P; Just M; Kochsiek K; Walter U
    Eur J Biochem; 1994 Oct; 225(1):21-7. PubMed ID: 7925440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Von Willebrand factor activates endothelial nitric oxide synthase in blood platelets by a glycoprotein Ib-dependent mechanism.
    Riba R; Oberprieler NG; Roberts W; Naseem KM
    J Thromb Haemost; 2006 Dec; 4(12):2636-44. PubMed ID: 17100655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Megakaryocyte hyperplasia and enhanced agonist-induced platelet activation in vasodilator-stimulated phosphoprotein knockout mice.
    Hauser W; Knobeloch KP; Eigenthaler M; Gambaryan S; Krenn V; Geiger J; Glazova M; Rohde E; Horak I; Walter U; Zimmer M
    Proc Natl Acad Sci U S A; 1999 Jul; 96(14):8120-5. PubMed ID: 10393958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A predominant role for cAMP-dependent protein kinase in the cGMP-induced phosphorylation of vasodilator-stimulated phosphoprotein and platelet inhibition in humans.
    Li Z; Ajdic J; Eigenthaler M; Du X
    Blood; 2003 Jun; 101(11):4423-9. PubMed ID: 12576312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ginsenoside-Rp3 inhibits platelet activation and thrombus formation by regulating MAPK and cyclic nucleotide signaling.
    Irfan M; Jeong D; Kwon HW; Shin JH; Park SJ; Kwak D; Kim TH; Lee DH; Park HJ; Rhee MH
    Vascul Pharmacol; 2018 Oct; 109():45-55. PubMed ID: 29890296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concentration and regulation of cyclic nucleotides, cyclic-nucleotide-dependent protein kinases and one of their major substrates in human platelets. Estimating the rate of cAMP-regulated and cGMP-regulated protein phosphorylation in intact cells.
    Eigenthaler M; Nolte C; Halbrügge M; Walter U
    Eur J Biochem; 1992 Apr; 205(2):471-81. PubMed ID: 1315268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombopoietin complements G(i)- but not G(q)-dependent pathways for integrin {alpha}(IIb){beta}(3) activation and platelet aggregation.
    Campus F; Lova P; Bertoni A; Sinigaglia F; Balduini C; Torti M
    J Biol Chem; 2005 Jul; 280(26):24386-95. PubMed ID: 15863506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nobiletin, a citrus flavonoid, activates vasodilator-stimulated phosphoprotein in human platelets through non-cyclic nucleotide-related mechanisms.
    Jayakumar T; Lin KC; Lu WJ; Lin CY; Pitchairaj G; Li JY; Sheu JR
    Int J Mol Med; 2017 Jan; 39(1):174-182. PubMed ID: 27959381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Off-target effect of the Epac agonist 8-pCPT-2'-O-Me-cAMP on P2Y12 receptors in blood platelets.
    Herfindal L; Nygaard G; Kopperud R; Krakstad C; Døskeland SO; Selheim F
    Biochem Biophys Res Commun; 2013 Aug; 437(4):603-8. PubMed ID: 23850619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of adenosine diphosphate mediated platelet responsiveness for the stability of platelet integrity in citrated whole blood under ex vivo conditions.
    Koessler J; Schwarz M; Weber K; Etzel J; Koessler A; Boeck M; Kobsar A
    PLoS One; 2017; 12(11):e0188193. PubMed ID: 29155852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The thrombin inhibitors hirudin and Refludan(®) activate the soluble guanylyl cyclase and the cGMP pathway in washed human platelets.
    Kobsar A; Koessler J; Kehrer L; Gambaryan S; Walter U
    Thromb Haemost; 2012 Mar; 107(3):521-9. PubMed ID: 22234363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet rap1B phosphorylation is a sensitive marker for the action of cyclic AMP- and cyclic GMP-increasing platelet inhibitors and vasodilators.
    Grünberg B; Kruse HJ; Negrescu EV; Siess W
    J Cardiovasc Pharmacol; 1995 Apr; 25(4):545-51. PubMed ID: 7596121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylation of the guanine-nucleotide-exchange factor CalDAG-GEFI by protein kinase A regulates Ca(2+)-dependent activation of platelet Rap1b GTPase.
    Guidetti GF; Manganaro D; Consonni A; Canobbio I; Balduini C; Torti M
    Biochem J; 2013 Jul; 453(1):115-23. PubMed ID: 23600630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiplatelet effects of caffeic acid due to Ca(2＋) mobilizationinhibition via cAMP-dependent inositol-1, 4, 5-trisphosphate receptor phosphorylation.
    Lee DH; Kim HH; Cho HJ; Bae JS; Yu YB; Park HJ
    J Atheroscler Thromb; 2014; 21(1):23-37. PubMed ID: 24088646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.